Ellen C. Obermann

3.6k total citations · 1 hit paper
76 papers, 2.8k citations indexed

About

Ellen C. Obermann is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ellen C. Obermann has authored 76 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 23 papers in Molecular Biology and 22 papers in Pathology and Forensic Medicine. Recurrent topics in Ellen C. Obermann's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Cancer Cells and Metastasis (7 papers). Ellen C. Obermann is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Cancer Cells and Metastasis (7 papers). Ellen C. Obermann collaborates with scholars based in Switzerland, Germany and United States. Ellen C. Obermann's co-authors include Marija Plodinec, Roderick Y. H. Lim, Philipp Oertle, Rosanna Zanetti‐Dällenbach, Cora‐Ann Schoenenberger, Ueli Aebi, Christophe Monnier, Mohamed Bentires‐Alj, Marko Loparić and Alexandar Tzankov and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Nature Nanotechnology.

In The Last Decade

Ellen C. Obermann

73 papers receiving 2.7k citations

Hit Papers

The nanomechanical signature of breast cancer 2012 2026 2016 2021 2012 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The nanomechanical signature of breast cancer
    2012 855 citations Marija Plodinec, Marko Loparić et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen C. Obermann Switzerland 26 1.1k 871 663 466 454 76 2.8k
Ben‐Zion Katz Israel 23 436 0.4× 1.1k 1.3× 1.4k 2.1× 320 0.7× 101 0.2× 62 2.8k
Janna K. Mouw United States 18 1.3k 1.2× 1.8k 2.1× 1.8k 2.7× 707 1.5× 94 0.2× 27 5.0k
Frédéric Saltel France 34 1.0k 1.0× 2.1k 2.4× 1.5k 2.3× 480 1.0× 88 0.2× 73 4.4k
Nelly Kieffer Luxembourg 29 344 0.3× 1.0k 1.2× 888 1.3× 310 0.7× 83 0.2× 61 2.9k
Ewan J. McGhee United Kingdom 22 597 0.6× 969 1.1× 732 1.1× 240 0.5× 56 0.1× 43 2.4k
Chris D. Madsen Sweden 19 1.0k 0.9× 1.1k 1.2× 672 1.0× 666 1.4× 67 0.1× 33 2.6k
Trevor D. McKee Canada 23 834 0.8× 1.3k 1.5× 404 0.6× 547 1.2× 75 0.2× 54 3.6k
Scott Floyd United States 22 808 0.7× 958 1.1× 505 0.8× 188 0.4× 143 0.3× 83 2.5k
Stephanie Alexander United States 16 1.3k 1.2× 1.5k 1.7× 1.9k 2.9× 482 1.0× 74 0.2× 23 4.3k
Michael W. Pickup United States 22 1.9k 1.8× 1.8k 2.0× 812 1.2× 783 1.7× 152 0.3× 32 4.0k

Countries citing papers authored by Ellen C. Obermann

Since Specialization
Citations

This map shows the geographic impact of Ellen C. Obermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen C. Obermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen C. Obermann more than expected).

Fields of papers citing papers by Ellen C. Obermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen C. Obermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen C. Obermann. The network helps show where Ellen C. Obermann may publish in the future.

Co-authorship network of co-authors of Ellen C. Obermann

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen C. Obermann. A scholar is included among the top collaborators of Ellen C. Obermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen C. Obermann. Ellen C. Obermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gachechiladze, Mariam, Sara Nizzero, Sabine Schädelin, et al.. (2024). Abstract 6394: Tissue nanomechanical signature predicts response to neoadjuvant chemotherapy in patients with breast cancer. Cancer Research. 84(6_Supplement). 6394–6394.
2.
3.
Wicki, Andreas, Christoph Mamot, Khalil Zaman, et al.. (2021). 268P Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple-negative, EGFR positive breast cancer: A multicenter single arm phase II trial [SAKK 24/14]. Annals of Oncology. 32. S479–S479. 4 indexed citations
4.
Noske, Aurelia, Simone Brandt, Nadejda Valtcheva, et al.. (2016). Detection ofCCNE1/URI(19q12) amplification byin situhybridisation is common in high grade and type II endometrial cancer. Oncotarget. 8(9). 14794–14805. 13 indexed citations
5.
Muenst, Simone, Savas D. Soysal, Feng Gao, et al.. (2013). The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer. Breast Cancer Research and Treatment. 139(3). 667–676. 274 indexed citations
6.
Savic, Spasenija, Beata Bode, Joachim Diebold, et al.. (2013). Detection of ALK-Positive Non–Small-Cell Lung Cancers on Cytological Specimens: High Accuracy of Immunocytochemistry with the 5A4 Clone. Journal of Thoracic Oncology. 8(8). 1004–1011. 76 indexed citations
7.
Savic, Spasenija, et al.. (2013). Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization. Journal of Thoracic Oncology. 9(1). 41–49. 50 indexed citations
8.
Brault, Laurent, Thomas Menter, Ellen C. Obermann, et al.. (2012). PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma. British Journal of Cancer. 107(3). 491–500. 54 indexed citations
9.
Lehr, Hans‐Anton, Sandrine Vijgen, Ellen C. Obermann, et al.. (2012). Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomas. Modern Pathology. 26(3). 336–342. 13 indexed citations
10.
Adams, Heiner, Ellen C. Obermann, Stephan Dirnhofer, & Alexandar Tzankov. (2011). Targetable molecular pathways in classical Hodgkin's lymphoma. Expert Opinion on Investigational Drugs. 20(2). 141–151. 3 indexed citations
11.
Sterlacci, William, Michael Fiegl, Wolfgang Hilbe, et al.. (2010). Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405 Operated Patients. Journal of Thoracic Oncology. 5(9). 1325–1336. 43 indexed citations
12.
Obermann, Ellen C., et al.. (2010). Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia. Annals of Hematology. 89(7). 663–669. 15 indexed citations
13.
Denzinger, Stefan, Maximilian Burger, Christine G. Hammerschmied, et al.. (2008). Pax-5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcome. Pathology. 40(5). 465–469. 7 indexed citations
14.
Grube, Matthias, Ellen C. Obermann, Katayoun Rezvani, et al.. (2007). CD8+ T cells Reactive to Survivin Antigen in Patients with Multiple Myeloma. Clinical Cancer Research. 13(3). 1053–1060. 27 indexed citations
15.
Roesch, Alexander, et al.. (2007). A woman with a dangling digit. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 5(11). 1008–1009. 1 indexed citations
16.
Bürger, M., et al.. (2007). Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade. British Journal of Cancer. 96(11). 1711–1715. 54 indexed citations
17.
Obermann, Ellen C., Philip Went, Alexandar Tzankov, et al.. (2006). Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase. Journal of Clinical Pathology. 60(7). 794–797. 19 indexed citations
18.
19.
Kammerl, Martin, et al.. (2001). RENAL TRANSPLANTATION IN A PATIENT WITH END STAGE RENAL DISEASE DUE TO CHOLESTEROL EMBOLISM. Transplantation. 71(1). 149–151. 3 indexed citations
20.
Obermann, Ellen C., Sylvia Bele, Alexander Brawanski, Ruth Knuechel, & Ferdinand Hofstaedter. (1999). Ossifying lipoma: a case report. University of Regensburg Publication Server (University of Regensburg). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ben‐Zion Katz Breakdown of academic impact, for papers by Janna K. Mouw Breakdown of academic impact, for papers by Frédéric Saltel Breakdown of academic impact, for papers by Nelly Kieffer Breakdown of academic impact, for papers by Ewan J. McGhee Breakdown of academic impact, for papers by Chris D. Madsen Breakdown of academic impact, for papers by Trevor D. McKee Breakdown of academic impact, for papers by Scott Floyd Breakdown of academic impact, for papers by Stephanie Alexander Breakdown of academic impact, for papers by Michael W. Pickup
Rankless by CCL
2026